Myocardial no reflow after percutaneous coronary intervention (PCI) is associated with poor outcome. Patients with ST-segment elevation myocardial infarction (STEMI) caused by plaque rupture are at high risk for no reflow. However, specific morphologic characteristics associated with no reflow are unknown in this population. The aim of this study is to identify the morphological characteristics of culprit plaques associated with no reflow in patients with STEMI caused by plaque rupture using both optical coherence tomography (OCT) and intravascular ultrasound (IVUS).
Introduction
Although primary percutaneous coronary intervention (PCI) with stenting is the most effective treatment strategy for patients with ST-segment elevation myocardial infarction (STEMI), 'no reflow' phenomenon occurs in 15-60% of patients. 1 -3 No reflow is associated with poor outcomes, including increased mortality and left ventricular dysfunction. 2 -5 Among various underlying mechanisms for acute coronary thrombosis, plaque rupture is the most common aetiology (60 -70%) and is associated with the worst outcome. 6 -8 However, the specific morphologic characteristics associated with no reflow in patients with STEMI caused by plaque rupture are unknown. Previous intravascular imaging studies have identified plaque rupture, 9 large plaque burden, 10, 11 large necrotic core, 12 greater remodelling index, 13 thin-capped fibroatheroma (TCFA), 14 and thrombus as predictors of no reflow. 10 Optical coherence tomography (OCT) has higher resolution than intravascular ultrasound (IVUS) and therefore provides more information on detailed morphological features such as thin fibrous cap and superficial lipid. 15 The aim of this study was to identify microscopic and macroscopic morphological characteristics of culprit plaques associated with no reflow in patients with STEMI caused by plaque rupture using both OCT and IVUS.
Methods

Study population and PCI procedures
This was a retrospective study. The subjects in this study were a subgroup of our previous study. 6 Of the 145 patients with STEMI who were admitted to Hirosaki University Hospital (Hirosaki, Japan) between January 2013 and June 2014 and who provided written informed consent for the primary PCI procedure, 72 patients who underwent both OCT and IVUS as a part of their routine care and who were found to have plaque rupture by OCT imaging were retrospectively included. STEMI was defined as an elevated creatine kinase myocardial isoform (CK-MB) and/or cardiac troponin T value greater than the upper reference limit with typical chest pain lasting . 20 min and ECG showing a new ST-segment elevation of ≥2 mm in at least two contiguous precordial electrocardiogram leads, ≥1 mm in at least two contiguous limb leads, or a newly apparent left bundle branch block. Patients with cardiogenic shock (n ¼ 4), unsuccessful reperfusion to achieve antegrade flow after aspiration thrombectomy (n ¼ 3), in-stent thrombosis (n ¼ 3), inability to advance an intravascular OCT imaging catheter to the culprit lesion (n ¼ 5), inability to advance an IVUS imaging catheter (n ¼ 8), poor image quality (n ¼ 4), massive thrombus (n ¼ 4), coronary embolism (n ¼ 2), and STEMI caused by other mechanisms [plaque erosion (n ¼ 30), calcified nodule (n ¼ 9), and spontaneous coronary dissection (n ¼ 1)] were excluded. Aspirin 200 mg, clopidogrel 300 mg, and heparin 100 IU/kg were administered prior to the procedure. All patients underwent the interventional procedure within 12 h of symptom onset, and stents were placed in all patients. Prior to the final coronary angiogram, intracoronary isosorbide dinitrate (0.5 -1.0 mg) and/or nicorandil (1.0 -2.0 mg) was given at the discretion of the operator.
All images were de-identified, digitally stored, and sent to Massachusetts General Hospital (MGH) (Boston, MA) for analysis. The patients were classified as having either myocardial no reflow or normal flow based on the final angiogram. Angiographic, OCT, IVUS, and patient characteristics were compared between the two groups. This collaborative study was approved by the institutional review boards at MGH and Hirosaki University Hospital.
Acquisition of OCT and IVUS image
Both OCT and IVUS were performed at the culprit lesion following manual aspiration thrombectomy, which was repeated until antegrade coronary flow was restored and analysable image quality was achieved. The details of OCT and IVUS methods were described in our previous manuscript. 6 
Angiographic analysis
Coronary angiograms performed before intervention, after thrombectomy, and at the end of the procedure were analysed for Thrombolysis in Myocardial Infarction (TIMI) criteria 16 and final myocardial blush grade. 17 Thrombus score at baseline was graded as previously described by the TIMI Study Group. 18 Myocardial no reflow was defined as TIMI flow grade ≤ 2 and/or myocardial blush grade ≤ 1 on the final angiogram. 19 Reference diameter, minimal lumen diameter (MLD), % diameter stenosis, and lesion length were also measured. Coronary angiograms were analysed using an offline quantitative coronary angiography programme (CAAS version 5. 10. 1, Pie Medical Imaging BV, Maastricht, The Netherlands).
OCT analysis
OCT images from the entire length of the culprit lesion plus proximal and distal segments of 5 mm were included in the analysis. Plaque rupture was defined by the presence of fibrous cap disruption with a communication between the lumen and inner lipid core, or with cavity formation within the plaque ( Figure 1A and B left panel). 6, 7 Detailed tissue characterization of the underlying plaque was performed according to the previously established criteria. 20 Crosssectional images were analysed at every 1-mm interval spanning the whole plaque length, and the thinnest fibrous cap thickness (FCT), maximal lipid arc, lipid length, and lipid index were recorded. Lipid index was calculated as the average of lipid arc multiplied by lipid length. TCFA was defined as a plaque with lipid arc . 908 and the thinnest FCT , 65 mm. Calcifications were defined as signal-poor or heterogeneous regions with sharply delineated borders. Thrombus was defined as an irregular mass protruding into the lumen and was semiquantitatively assessed using the sum of involved quadrants in each 1-mm interval cross section. 21 All OCT images were analysed by two experienced investigators who were blinded to the angiographic data and clinical presentations. When there was discordance between the observers, a consensus reading was obtained from another investigator.
IVUS analysis
Quantitative IVUS measurements included external elastic membrane (EEM) cross-sectional area (CSA), lumen CSA, and plaque plus media (P + M) CSA at the lesion site (cross section with the minimal lumen CSA) and reference sites. Plaque burden was calculated as the lesion P + M CSA divided by the lesion EEM CSA multiplied by 100. 22 Reference sites were identified as the least diseased cross-sectional images within 10 mm proximal and distal to the culprit lesion. Plaque eccentricity index was calculated as (maximal P + M thickness minus minimal P + M thickness) divided by maximal P + M thickness. The remodelling index was calculated as the EEM CSA at the lesion site divided by the average of the proximal and distal reference EEM CSA. 22 All IVUS images were analysed by two experienced investigators who were blinded to the angiographic data and clinical presentations. When there was discordance between the observers, a consensus reading was obtained from another investigator.
Statistical analysis
Categorical outcomes are presented as counts and percentages (%), and Fisher's exact test or x 2 tests were used as appropriate.
The distributions of continuous variables were evaluated with the Kolmogorov -Smirnov test. The mean with standard deviation is reported when data were normally distributed, and the median with 25th and 75th percentiles is reported when data were not normally distributed. Continuous variables were compared by Student's t-test or the Mann -Whitney U test as appropriate.
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Receiver-operating characteristic (ROC) curve analyses were performed to determine the best cut-off values (using the Youden index) of morphological characteristics for differentiating no reflow and normal flow, and the areas under the curve (AUC), sensitivity, specificity, and positive and negative predictive values for the diagnostic test. A P-value of ,0.05 was considered statistically significant. All statistical analyses were performed using SPSS 17.0 (SPSS, Inc., Chicago, IL).
Results
Baseline characteristics
Among the 72 cases of STEMI caused by plaque rupture, the incidence of myocardial no reflow was 38.9% (n ¼ 28). Final TIMI flow grade ≤ 2 was observed in 20.8% (n ¼ 15), myocardial blush grade ≤ 1 in 30.6% (n ¼ 22), and both final TIMI flow grade ≤ 2 and myocardial blush grade ≤ 1 in 12.5% (n ¼ 9) of cases. Baseline clinical and angiographic characteristics are shown in Tables 1 and 2 . Patients with no reflow were older than those with normal flow (P ¼ 0.029). Although the incidence of dyslipidaemia was similar between the two groups, patients with no reflow were more frequently treated with statin on admission. Consistent with the higher incidence of statin use in the no reflow group, these patients presented with lower total cholesterol levels on admission than those in the normal flow group (P ¼ 0.034). In addition, the no reflow group had a higher incidence of complex lesions (P ¼ 0.010) and baseline TIMI flow ≤ 1 (P ¼ 0.029) than the normal flow group. Although there was no significant difference, a trend towards a higher incidence of large thrombus (thrombus score 3 -5) was found in the no reflow group on baseline angiogram (P ¼ 0.078). ). IVUS, intravascular ultrasound; OCT, optical coherence tomography.
Predictors for no reflow in STEMI
OCT findings
Although the thinnest FCT and lipid length were similar between the two groups, the maximal lipid arc (P ¼ 0.032) and lipid index (P , 0.001) were greater in the no reflow group than in the normal flow group ( Table 3) . The incidence of TCFA and thrombus score was similar between the two groups.
IVUS findings
Compared with the normal flow group, the no reflow group had larger EEM CSA and P + M CSA at the lesion site (P ¼ 0.026 and P ¼ 0.021, respectively). The no reflow group also had larger plaque burden (P ¼ 0.003) and lower eccentricity index (P ¼ 0.049) ( Table 4) .
Discriminators of no reflow
ROC curve analysis was performed to identify OCT parameters (maximum lipid arc, lipid index) and IVUS parameters (EEM CSA, P + M CSA, plaque burden, and plaque eccentricity index) that could be useful in differentiating cases with no reflow from those with normal flow (Figure 2) . The best cut-off values to predict no reflow were a maximal lipid arc of .2858, lipid index . 3500, EEM CSA . 19.0 mm 2 , P + M CSA . 16.0 mm 2 , plaque burden .
81.5%, and plaque eccentricity index , 0.40 (Table 5) . OCT-derived lipid index had the best predictive value for no reflow (AUC ¼ 0.77, P , 0.001), and IVUS-derived plaque burden had good performance in discriminating no reflow (AUC ¼ 0.70, P ¼ 0.002).
Post PCI outcome
Compared with the normal flow group, the no reflow group demonstrated higher peak CK (2608. 
Discussion
To the best of our knowledge, this study is the first detailed investigation using both OCT and IVUS to explore culprit plaque characteristics discriminating no reflow in patients with STEMI caused by plaque rupture. This combined OCT and IVUS study demonstrates that OCT-derived lipid index and IVUS-derived plaque burden are good discriminators to predict no reflow. Previous IVUS studies have demonstrated an incidence of plaque rupture of 87% in lesions with abnormal TIMI flow after primary PCI for STEMI, compared with 51% of lesions with normal flow. 9 Other IVUS studies have shown a correlation between large plaque burden, 10 the culprit lesions of patients with ACS and abnormal TIMI flow after PCI. Among non-ST-segment elevation ACS patients, OCT-detected TCFA has been reported to be a predictor of no reflow. 14 Importantly, these are the same parameters commonly seen with ruptured plaques. 23 As plaque rupture is associated with a higher incidence of TCFA and large lipid burden compared with plaque erosion, 6,7 risk stratification for no reflow may be of particular importance in patients presenting with STEMI caused by plaque rupture. Our data suggested that large lipid core at STEMI culprit lesions with plaque rupture is an important determinant of no reflow after primary PCI.
In this study, we demonstrate that larger maximal lipid arc, lipid index, EEM CSA, P + M CSA, and plaque burden are associated with no reflow after primary PCI in patients with STEMI caused by plaque rupture. These findings indicate that large lipid burden is a major determinant of no reflow, even in STEMI culprit lesions with ruptured plaque. When the vascular wall is injured by stent struts during PCI, a large amount of lipid content can flow into the coronary artery, increasing local thrombogenicity 24 and disturbing the distal coronary microcirculation. We demonstrate that OCT-derived lipid index and IVUS-derived plaque burden are critical discriminators of no reflow. Although the maximal lipid arc in the no reflow group was significantly wider than in the normal reflow group, most lesions had circumferential lipid and the numerical difference was small. That is probably why maximal lipid arc did not become a strong discriminator of no reflow. The IVUS findings showed that plaque burden was significantly larger in the no reflow group than in the normal reflow group. Although the numerical difference also appears to be small, plaque burden . 81.5% demonstrated a high sensitivity and high negative predictive value. However, it should be noted that more than a half of patients with normal reflow had plaque burden . 81.5%. We also found that ruptured concentric plaques, in contrast to eccentric plaques, are more frequently associated with no reflow. In these lesions, lipid is distributed around the entire vessel circumference such that, when a stent is implanted, lipid content may easily be released into the lumen and flow into distal segments. In the setting of STEMI, the presence of thrombus is also associated with no reflow. 13 There was a trend towards higher incidence of large thrombus burden at baseline in the no reflow group. Although we performed repeated aspiration thrombectomy prior to balloon angioplasty or stenting, it is possible that baseline thrombus burden might have affected no reflow outcome. In contrast to a prior study, 13 we did not identify a significant difference in remodelling index between cases with no reflow vs. normal flow. A potential explanation for this discrepancy is that our study included only patients with STEMI caused by plaque rupture. We also did not observe a difference in thrombus score between patients with no reflow and normal flow, likely due to intravascular imaging being performed after repeated aspiration thrombectomy. Time delay to reperfusion has been shown to be an important determinant of no reflow, 23 as prolonged ischaemia and delayed reperfusion can impair endothelial function and cause myocardial oedema or haemorrhage. 19 There was, however, no significant difference between the groups in time delay from symptom onset to reperfusion. This discrepancy may relate to the multifactorial pathogenic mechanisms underlying no reflow in acute myocardial infarction (AMI), including distal embolization, ischaemic injury, reperfusion injury, and individual sensitivity. 19 We did, however, find a significant association between age and no reflow. This finding was expected, as aging is associated with impaired endothelial function through inhibition of nitric oxide synthase activity, increased reactive oxygen species, inflammatory reactions, reduced number and function of endothelial progenitor cells, impaired telomerase activity, and telomere shortening. 25 A large multicentre study, including both STEMI and non-STEMI patients, also identified age as an independent predictor of no reflow. 4 To date, the efficacy of distal protection in primary PCI remains unproved. 26, 27 Prior studies, however, have included patients with AMI caused by different underlying mechanisms. Patients with AMI caused by plaque rupture with a large OCT-derived lipid index or IVUS-derived plaque burden may represent a subgroup at high risk for no reflow, who might therefore benefit from distal protection during primary PCI.
Limitations
Although this is the first detailed study of no reflow in patients with STEMI caused by plaque rupture, there are several limitations that should be acknowledged. First, the present study is a single-centre study which was analysed retrospectively. Second, the number of eligible subjects in this study was small. A half of the patients with STEMI admitted during the study period were excluded and, therefore, it is possible that potential selection bias might have influenced the results. We believe that since patients with STEMI caused by plaque rupture have poor prognosis, 6, 8 it is important to identify the discriminators of no reflow in this high-risk subgroup. A future study using a larger sample size is needed to confirm our findings. Third, the two groups were not perfectly balanced due to sample size. The no reflow group had a higher prevalence of statin use. Interestingly, statin treatment prior to PCI is known to reduce the incidence of no reflow. 28 Fourth, thrombectomy was performed prior to intravascular imaging evaluation. Although careful attention was paid to avoid excessive mechanical injury during thrombectomy, it is possible that thrombectomy may have altered the morphological features of the underlying plaque. Fifth, residual thrombus can limit the quality and accuracy of OCT evaluation. We therefore excluded four patients with significant residual thrombus from analysis. Sixth, due to the limited tissue penetration, OCT is less robust for the assessment of plaque volume or lipid volume, and as a result, lipid index was used in this study. We performed a logistic model-based ROC analysis to determine if the AUC of the model with two parameters (plaque burden and lipid index) improved that of the model with lipid index alone. Although independently predicted no reflow, the combination of these two parameters did not significantly improve the predictability of lipid index (ROC AUC of 0.78 vs. 0.77). Seventh, we could not study patients who were pre-treated with a glycoprotein IIb/IIIa inhibitor, because the drug was not 
Conclusions
This study demonstrates that OCT-derived lipid index and IVUSderived plaque burden are good discriminators to detect no reflow. OCT and IVUS may therefore be useful in guiding PCI strategy in patients with STEMI, as distal protection devices may be particularly beneficial when treating lesions with high-risk features for no reflow. 
